These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23948974)

  • 1. The integrin inhibitor cilengitide affects meningioma cell motility and invasion.
    Wilisch-Neumann A; Kliese N; Pachow D; Schneider T; Warnke JP; Braunsdorf WE; Böhmer FD; Hass P; Pasemann D; Helbing C; Kirches E; Mawrin C
    Clin Cancer Res; 2013 Oct; 19(19):5402-12. PubMed ID: 23948974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cilengitide inhibits metastatic bone colonization in a nude rat model.
    Bretschi M; Merz M; Komljenovic D; Berger MR; Semmler W; Bäuerle T
    Oncol Rep; 2011 Oct; 26(4):843-51. PubMed ID: 21725616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cilengitide targets pediatric glioma and neuroblastoma cells through cell detachment and anoikis induction.
    Leblond P; Dewitte A; Le Tinier F; Bal-Mahieu C; Baroncini M; Sarrazin T; Lartigau E; Lansiaux A; Meignan S
    Anticancer Drugs; 2013 Sep; 24(8):818-25. PubMed ID: 23728220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miRNA-145 is downregulated in atypical and anaplastic meningiomas and negatively regulates motility and proliferation of meningioma cells.
    Kliese N; Gobrecht P; Pachow D; Andrae N; Wilisch-Neumann A; Kirches E; Riek-Burchardt M; Angenstein F; Reifenberger G; Riemenschneider MJ; Meese E; Panayotova-Dimitrova D; Gutmann DH; Mawrin C
    Oncogene; 2013 Sep; 32(39):4712-20. PubMed ID: 23108408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cilengitide modulates attachment and viability of human glioma cells, but not sensitivity to irradiation or temozolomide in vitro.
    Maurer GD; Tritschler I; Adams B; Tabatabai G; Wick W; Stupp R; Weller M
    Neuro Oncol; 2009 Dec; 11(6):747-56. PubMed ID: 19221171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between laminin γ1 expression and meningioma grade, recurrence, and progression-free survival.
    Ke HL; Ke RH; Li B; Wang XH; Wang YN; Wang XQ
    Acta Neurochir (Wien); 2013 Jan; 155(1):165-71. PubMed ID: 23053286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.
    Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H
    Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NDRG4, the N-Myc downstream regulated gene, is important for cell survival, tumor invasion and angiogenesis in meningiomas.
    Kotipatruni RP; Ferraro DJ; Ren X; Vanderwaal RP; Thotala DK; Hallahan DE; Jaboin JJ
    Integr Biol (Camb); 2012 Oct; 4(10):1185-97. PubMed ID: 22869042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mTORC1 inhibitors suppress meningioma growth in mouse models.
    Pachow D; Andrae N; Kliese N; Angenstein F; Stork O; Wilisch-Neumann A; Kirches E; Mawrin C
    Clin Cancer Res; 2013 Mar; 19(5):1180-9. PubMed ID: 23406776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of systemic celecoxib on human meningioma after intracranial transplantation into nude mice.
    Friedrich S; Schwabe K; Grote M; Krauss JK; Nakamura M
    Acta Neurochir (Wien); 2013 Jan; 155(1):173-82. PubMed ID: 23143216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cilengitide targeting of alpha(v)beta(3) integrin receptor synergizes with radioimmunotherapy to increase efficacy and apoptosis in breast cancer xenografts.
    Burke PA; DeNardo SJ; Miers LA; Lamborn KR; Matzku S; DeNardo GL
    Cancer Res; 2002 Aug; 62(15):4263-72. PubMed ID: 12154028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SU11657 enhances radiosensitivity of human meningioma cells.
    Milker-Zabel S; Zabel-du Bois A; Ranai G; Trinh T; Unterberg A; Debus J; Lipson KE; Abdollahi A; Huber PE
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1213-8. PubMed ID: 18234428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
    Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A
    APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma cells in culture and in meningioma transplants by induction of the apoptotic pathway.
    Schrell UM; Rittig MG; Anders M; Kiesewetter F; Marschalek R; Koch UH; Fahlbusch R
    J Neurosurg; 1997 May; 86(5):845-52. PubMed ID: 9126901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role for matrix remodelling proteins in invasive and malignant meningiomas.
    Jalali S; Singh S; Agnihotri S; Wataya T; Salehi F; Alkins R; Burrell K; Navab R; Croul S; Aldape K; Zadeh G
    Neuropathol Appl Neurobiol; 2015 Feb; 41(2):e16-28. PubMed ID: 24989599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cilengitide inhibits attachment and invasion of malignant pleural mesothelioma cells through antagonism of integrins αvβ3 and αvβ5.
    Cheng NC; van Zandwijk N; Reid G
    PLoS One; 2014; 9(3):e90374. PubMed ID: 24595274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas.
    Bush ML; Oblinger J; Brendel V; Santarelli G; Huang J; Akhmametyeva EM; Burns SS; Wheeler J; Davis J; Yates CW; Chaudhury AR; Kulp S; Chen CS; Chang LS; Welling DB; Jacob A
    Neuro Oncol; 2011 Sep; 13(9):983-99. PubMed ID: 21778190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor tyrosine kinase inhibition by regorafenib/sorafenib inhibits growth and invasion of meningioma cells.
    Tuchen M; Wilisch-Neumann A; Daniel EA; Baldauf L; Pachow D; Scholz J; Angenstein F; Stork O; Kirches E; Mawrin C
    Eur J Cancer; 2017 Mar; 73():9-21. PubMed ID: 28082204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrin control of the transforming growth factor-β pathway in glioblastoma.
    Roth P; Silginer M; Goodman SL; Hasenbach K; Thies S; Maurer G; Schraml P; Tabatabai G; Moch H; Tritschler I; Weller M
    Brain; 2013 Feb; 136(Pt 2):564-76. PubMed ID: 23378223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha(v)beta3 and alpha(v)beta5 integrin expression in meningiomas.
    Bello L; Zhang J; Nikas DC; Strasser JF; Villani RM; Cheresh DA; Carroll RS; Black PM
    Neurosurgery; 2000 Nov; 47(5):1185-95. PubMed ID: 11063113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.